AUD 1.18
(-1.67%)
Year | Revenue | Revenue Growth |
---|---|---|
2024 | 4 Million AUD | 27.73% |
2023 | 3.13 Million AUD | 342.83% |
2022 | 707.8 Thousand AUD | 82.71% |
2021 | 387.38 Thousand AUD | 143.07% |
2020 | 159.37 Thousand AUD | -30.25% |
2019 | 228.5 Thousand AUD | 34.21% |
2018 | 170.26 Thousand AUD | 0.0% |
2017 | - AUD | 0.0% |
2016 | - AUD | 0.0% |
2015 | - AUD | 0.0% |
2014 | - AUD | 0.0% |
2013 | - AUD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 4 Million AUD | 0.0% |
2024 Q4 | - AUD | 0.0% |
2024 FY | - AUD | -100.0% |
2023 Q2 | 1.32 Million AUD | 0.0% |
2023 FY | 3.13 Million AUD | 342.83% |
2023 Q4 | 1.81 Million AUD | 0.0% |
2022 Q4 | - AUD | 0.0% |
2022 Q2 | 707.8 Thousand AUD | 0.0% |
2022 FY | 707.8 Thousand AUD | 82.71% |
2021 Q2 | 387.38 Thousand AUD | 0.0% |
2021 Q4 | - AUD | 0.0% |
2021 FY | 387.38 Thousand AUD | 143.07% |
2020 Q4 | - AUD | 0.0% |
2020 FY | 159.37 Thousand AUD | -30.25% |
2020 Q2 | 159.37 Thousand AUD | 0.0% |
2019 FY | 228.5 Thousand AUD | 34.21% |
2019 Q4 | - AUD | 0.0% |
2019 Q2 | 228.5 Thousand AUD | 0.0% |
2018 Q2 | 170.26 Thousand AUD | 0.0% |
2018 Q4 | - AUD | 0.0% |
2018 FY | 170.26 Thousand AUD | 0.0% |
2017 Q2 | - AUD | 0.0% |
2017 FY | - AUD | 0.0% |
2017 Q4 | - AUD | 0.0% |
2016 Q2 | - AUD | 0.0% |
2016 FY | - AUD | 0.0% |
2016 Q4 | - AUD | 0.0% |
2015 Q3 | - AUD | 0.0% |
2015 Q1 | - AUD | 0.0% |
2015 Q4 | - AUD | 0.0% |
2015 Q2 | - AUD | 0.0% |
2015 FY | - AUD | 0.0% |
2014 FY | - AUD | 0.0% |
2013 FY | - AUD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Memphasys Limited | 60 Thousand AUD | -6572.45% |
AdAlta Limited | 1.73 Million AUD | -130.376% |
Anatara Lifesciences Ltd | - AUD | -Infinity% |
Bio-Gene Technology Limited | 18.32 Thousand AUD | -21753.002% |
BTC Health Limited | 16.36 Thousand AUD | -24371.088% |
CSL Limited | 22.41 Billion AUD | 99.982% |
Clarity Pharmaceuticals Ltd | 11.5 Million AUD | 65.207% |
Cynata Therapeutics Limited | 2.31 Million AUD | -72.888% |
Imugene Limited | - AUD | -Infinity% |
NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
PharmAust Limited | - AUD | -Infinity% |
Proteomics International Laboratories Limited | 892.14 Thousand AUD | -348.748% |
Acrux Limited | 5.09 Million AUD | 21.362% |
Botanix Pharmaceuticals Limited | 601.82 Thousand AUD | -565.227% |
Clinuvel Pharmaceuticals Limited | 88.17 Million AUD | 95.46% |
Island Pharmaceuticals Limited | 1.25 Million AUD | -219.875% |
Nyrada Inc. | - AUD | -Infinity% |
Orthocell Limited | 5.31 Million AUD | 24.681% |
Radiopharm Theranostics Limited | 299.22 Thousand AUD | -1237.933% |
Starpharma Holdings Limited | 8.28 Million AUD | 51.701% |
Zelira Therapeutics Limited | 94.95 Thousand AUD | -4116.309% |
Arovella Therapeutics Limited | 17 Thousand AUD | -23449.824% |
Alterity Therapeutics Limited | 4.01 Million AUD | 0.393% |
Amplia Therapeutics Limited | 4.45 Million AUD | 10.09% |
Biome Australia Limited | 13 Million AUD | 69.225% |
Biotron Limited | - AUD | -Infinity% |
Chimeric Therapeutics Limited | 7.45 Million AUD | 46.317% |
EZZ Life Science Holdings Limited | 66.44 Million AUD | 93.975% |
Immutep Limited | 3.5 Million AUD | -14.198% |
Invex Therapeutics Ltd | 1.21 Million AUD | -230.25% |
Noxopharm Limited | 2.4 Million AUD | -66.792% |
Patrys Limited | 1.39 Million AUD | -187.159% |
Prescient Therapeutics Limited | 3.71 Million AUD | -7.842% |
PYC Therapeutics Limited | 22.05 Million AUD | 81.851% |
Telix Pharmaceuticals Limited | 496.65 Million AUD | 99.194% |
Dimerix Limited | 583.47 Thousand AUD | -586.139% |
Hexima Limited | - AUD | -Infinity% |
Neuren Pharmaceuticals Limited | 231.92 Million AUD | 98.274% |
Nanollose Limited | 12.5 Thousand AUD | -31925.198% |
Tissue Repair Ltd | 152.24 Thousand AUD | -2529.71% |
AnteoTech Limited | 460.39 Thousand AUD | -769.569% |
Paradigm Biopharmaceuticals Limited | 65.8 Thousand AUD | -5984.301% |
Recce Pharmaceuticals Ltd | - AUD | -Infinity% |
Avecho Biotechnology Limited | 473.55 Thousand AUD | -745.415% |
Actinogen Medical Limited | 9.93 Million AUD | 59.689% |
Immuron Limited | 4.9 Million AUD | 18.344% |
Argenica Therapeutics Limited | 2.59 Million AUD | -54.102% |